This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2023 Oct 2;65(1686):155-156.

doi: 10.58347/tml.2023.1686a.

Two vaccines (Arexvy and Abrysvo) for prevention of RSV disease

No authors listed

PMID: 37755690
DOI: 10.58347/tml.2023.1686a

Two vaccines (Arexvy and Abrysvo) for prevention of RSV disease

No authors listed. Med Lett Drugs Ther. 2023.

. 2023 Oct 2;65(1686):155-156.

doi: 10.58347/tml.2023.1686a.

PMID: 37755690
DOI: 10.58347/tml.2023.1686a

No abstract available

Keywords: Abrysvo; Arexvy; Beyfortus; RSV; Synagis; adverse effects; dosage; efficacy; nirsevimab; palivizumab; pregnancy; safety; vaccine.

PubMed Disclaimer

Similar articles

Nirsevimab (Beyfortus) for prevention of severe RSV disease in young children.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2023 Sep 18;65(1685):145-147. doi: 10.58347/tml.2023.1685a. Med Lett Drugs Ther. 2023. PMID: 37682698 No abstract available.
Comparative Cost-Effectiveness Analysis of Respiratory Syncytial Virus Vaccines for Older Adults in Hong Kong.
Wang Y, Fekadu G, You JHS. Wang Y, et al. Vaccines (Basel). 2023 Oct 17;11(10):1605. doi: 10.3390/vaccines11101605. Vaccines (Basel). 2023. PMID: 37897008 Free PMC article.
In brief: New warning for the RSV vaccines Arexvy and Abrysvo.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2025 Feb 17;67(1722):31-32. doi: 10.58347/tml.2025.1722d. Med Lett Drugs Ther. 2025. PMID: 39946699 No abstract available.
Respiratory Syncytial Virus Vaccine.
[No authors listed] [No authors listed] 2024 Aug 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Aug 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 38163332 Free Books & Documents. Review.
Recombinant respiratory syncytial virus (RSV) vaccines for older adults, and pregnant women to prevent disease in their infant.
[No authors listed] [No authors listed] Aust Prescr. 2024 Jun;47(3):100-101. doi: 10.18773/austprescr.2024.028. Aust Prescr. 2024. PMID: 38962385 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

Seasonal epidemiological and clinical characteristics of pediatric patients with respiratory syncytial virus infection by age during COVID-19: a cross-sectional study.
Xie LY, Peng YG, Wang T, Yu T, Hu X, Yang L, Zhong LL, Peng L, Zeng SZ. Xie LY, et al. Transl Pediatr. 2025 Jun 27;14(6):1168-1180. doi: 10.21037/tp-2025-62. Epub 2025 Jun 18. Transl Pediatr. 2025. PMID: 40688206 Free PMC article.
Use of the Abrysvo Vaccine in Pregnancy to Prevent Respiratory Syncytial Virus in Infants: A Review.
Patel D, Chawla J, Blavo C. Patel D, et al. Cureus. 2024 Aug 31;16(8):e68349. doi: 10.7759/cureus.68349. eCollection 2024 Aug. Cureus. 2024. PMID: 39355078 Free PMC article. Review.
Vaccine and therapeutic agents against the respiratory syncytial virus: resolved and unresolved issue.
Li Q, Li H, Li Z, Wang Y. Li Q, et al. MedComm (2020). 2024 Nov 21;5(12):e70016. doi: 10.1002/mco2.70016. eCollection 2024 Dec. MedComm (2020). 2024. PMID: 39575302 Free PMC article. Review.
Exploring Therapeutic Targets From Spreading Patterns Against Respiratory Syncytial Virus.
Zhang H, Zhang Z, Yang Y, Pei J. Zhang H, et al. FASEB J. 2025 Jul 31;39(14):e70858. doi: 10.1096/fj.202500509RR. FASEB J. 2025. PMID: 40689767 Free PMC article. Review.

LinkOut - more resources

Full Text Sources
- Medical Letter on Drugs and Therapeutics